Fmoc-AEEA-OH CAS NO.166108-71-0

[2-[2-(Fmoc- amino) ethoxy] ethoxy] acetic acid is a key intermediate compound in the synthesis of the anti-AIDS drug Alabotte and the diabetes treatment drug sommarutide. This modified PEG and its congeners can also be applied in drug development, for example, it can modify protein drugs, peptide compounds, liposomes through coupling reactions. And small molecule drugs.
[2-[2-(Fmoc- amino) ethoxy] ethoxy] acetic acid is an organic synthesis intermediate and pharmaceutical intermediate, which can be used in laboratory research and development and chemical and pharmaceutical synthesis process. At the same time, we are constantly optimizing the process, committed to reducing costs, ensuring safety, reducing waste liquid emissions and so on. At the same time, our production capacity is also steadily improving, solvent recycling, low carbon environmental protection. We have a strong cooperative factory, and it has been confirmed that the production capacity of this product can achieve 2 tons per month. If you have higher requirements, we will also consider adding equipment to meet customer needs. This product has cultivated dozens of customers in China, we provide high-quality after-sales service, so that each customer has a satisfactory feeling of use. Quality has always been our highest goal.  The purity of our products is higher than that of many in the same industry, and the price is very favorable.

Founded in December 2020, the company is committed to the process research and development and industrialization of pharmaceutical intermediates, chiral amino acids represented by D-penicillamine, and the process research and development and refining of raw materials represented by Tisirolimus. At the same time, our business scope also includes the development, production and sales of customized products. The company has well-equipped laboratories, modern analytical equipment, multi-functional kg laboratories and pilot production workshops. Relying on high quality and good customer service, we serve a wide range of pharmaceutical and biotechnology, agrochemical and specialty chemical companies around the world, covering FTE project research, small molecule compound synthesis, chemical process research and development, and production at different scales from kg to ton. At present, through independent research and development, the company has developed amino acid derivatives, a series of heterocyclic boric acid products and polypeptide pharmaceutical intermediates and other more than a dozen industrial products. The company adheres to the core values of "integrity, diligence, cooperation and innovation", and integrates a high-quality professional team of scientific research, management, production and marketing. The company's decision-making level is keen in thinking, advanced in consciousness, high in business quality, and rich in enterprise management experience. At present, the company has 9 R & D personnel, including 1 doctor and 2 master. We rely on technological innovation, actively build a modern enterprise management model, and strive to build the company into a first-class supplier of domestic pharmaceutical intermediates and fine chemical industry.